Arch Therapeutics, Inc. (QB) Stock Price - ARTH

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
ULTIMATE TRADER
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Arch Therapeutics, Inc. (QB) ARTH OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.01 -2.29% 0.4275 0.44 0.42 0.44 0.4375 16:00:05
Bid Price Ask Price Spread Spread % News
0.42 0.44 0.02 4.55% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
54 231,618 $ 0.4371 $ 101.24k 260.23k 0.26 - 0.69
Last Trade Time Type Quantity Stock Price Currency
15:59:15 50 $0.44 USD

Arch Therapeutics, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 69.34M 162.2M $ -2.95M - -23.52 148.6M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Arch Therapeutics, Inc. (QB) News

Date Time Source News Article
12/19/201807:34Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
12/18/201816:21Edgar (US Regulatory)Annual Report (10-k)
12/17/201808:08Edgar (US Regulatory)Current Report Filing (8-k)
12/06/201807:58Edgar (US Regulatory)Current Report Filing (8-k)
12/04/201807:54Edgar (US Regulatory)Current Report Filing (8-k)
11/28/201808:33Edgar (US Regulatory)Current Report Filing (8-k)
11/26/201809:07Edgar (US Regulatory)Current Report Filing (8-k)

Latest ARTH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARTH Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.4550.4650.4060.436624k232k109k-0.0275-6.04%
1 Month0.540.540.4060.484824k602k193k-0.1125-20.83%
3 Months0.38010.620.3010.470223k2M261k0.047412.47%
6 Months0.42010.620.3010.440712k2M229k0.00741.76%
1 Year0.4450.690.260.410412k3M274k-0.0175-3.93%
3 Years0.18510.9450.1710.536612k9M452k0.2424130.96%
5 Years0.380.9450.150.45722k9M381k0.047512.50%

Arch Therapeutics, Inc. (QB) Description

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include the AC5™ Topical Gel and the AC5™ Surgical Hemostatic Device.
Your Recent History
OTCBB
ARTH
Arch Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190119 22:25:44